Brief: To Help Prepare For The Covid-19 Patient Surge Cumberland Pharmaceuticals Expands Availability Of Vaprisol® To Treat Hyponatremia In Critical Care Units
07/04/2020 23:07
Cumberland Pharmaceuticals Inc CPIX.O :
* TO HELP PREPARE FOR THE COVID-19 PATIENT SURGE CUMBERLAND
PHARMACEUTICALS EXPANDS AVAILABILITY OF VAPRISOL® TO TREAT
HYPONATREMIA IN CRITICAL CARE UNITS
Source text for Eikon: ID:nPn8ZSS5Ha
Further company coverage: CPIX.O
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM